Trial site
The Fourth Hospital of Harbin Medical University
- 11running trials
- 6closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes5 trials
- Coronary artery disease2 trials
- Obesity2 trials
- Hepatitis B1 trial
- Osteoporosis1 trial
- Primary biliary cholangitis1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Completed6 trials
- Not yet recruiting3 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company5 trials
- Amgen3 trials
- Cascade Pharmaceuticals, Inc1 trial
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Fujian Medical University1 trial
- and 6 more
Running trials
Recruiting
Not yet recruiting
Recruiting
Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery
Active, not recruiting
Recruiting
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Active, not recruiting
Active, not recruiting
Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China
Active, not recruiting
Not yet recruiting
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease1 recruiting
- Hepatitis B1 recruiting
- Obesity1 recruiting
- Primary biliary cholangitis1 recruiting
Closed trials
Completed
To Evaluate the Efficacy and Safety of the Insulin Patch Pump System in Patients With Diabetes.
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026